Examination of Setarud (IMOD™) in the management of patients with severe sepsis

BACKGROUND AND THE PURPOSE OF THE STUDY: Analysis of current immunomodulating strategies indicates that monovalent approaches are unlikely to restore immunostasis or achieve complete therapy of sepsis. Setarud (IMOD) as a mixture of urtica, carotenoids, urea, and selenium has been recently patented...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoodpoor, A., Eslami, K., Mojtahedzadeh, M., Najafi, A., Ahmadi, A., Dehnadi-Moghadam, A., Mohammadirad, A., Baeeri, M., Abdollahi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232081/
https://www.ncbi.nlm.nih.gov/pubmed/22615589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232081/
https://www.ncbi.nlm.nih.gov/pubmed/22615589

Ejemplares similares